The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always the case that some of the top performing stocks each year come…
We have compiled a detailed list of expected upside in the biotech sector. The sector has consolidated and now there is about to be a rush of earnings reports from tomorrow’s emerging…
Biotech is becoming the ever-shrinking stock sector. It is almost weekly now that a new biotech acquisition is announced. Big Pharma in the United States and large drugmakers internationally are all interested in acquiring the…
The proposed buyout of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) should close this week. We are about to get a new Genzyme security on the market and that will be…
Futurists are an odd lot. Generally, they are authors, scientists, consultants and economists. What many people don’t know is that investors follow this philosophy as well. Their goal is to pick winning…
Today’s version of the BioHealth Business Daily is rather different as we have a big disappointment from one of the top biotech operations in the world. BioHealth stocks moving on news and…
